Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient

Richard A. Helmers, Thomas J. Byrne, Lewis J. Wesselius, Kevin O. Leslie

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Historically, the treatment of hepatitis C virus infection has been difficult, but therapeutic options have improved markedly recently because of the development of novel antiviral therapies. These therapies have been well tolerated. We describe a patient who was receiving such therapy and had development of temporally related and histologically confirmed severe pulmonary toxicity. Pulmonary toxicity should be considered a potential serious complication of novel antiviral therapy for hepatitis C virus infection.

Original languageEnglish (US)
Pages (from-to)1294-1297
Number of pages4
JournalMayo Clinic proceedings
Volume90
Issue number9
DOIs
StatePublished - Sep 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient'. Together they form a unique fingerprint.

Cite this